Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Okumura, Naoki ^a   Sakamoto, Yuji ^b   Fujii, Keita ^a   Kitano, Junji ^a   Nakano, Shinichiro ^a   Tsujimoto, Yuki ^a   Nakamura, Shin Ichiro ^c   Ueno, Morio ^d   Hagiya, Michio ^d   Hamuro, Junji ^d   Matsuyama, Akifumi ^e   Suzuki, Shingo ^f   Shiina, Takashi ^f   Kinoshita, Shigeru ^d   Koizumi, Noriko ^a  

^a DOSHISHA UNIVERSITY   (Japan)

^b SENJU PHARMACEUTICAL CO LTD   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e 567 0085 Japan   (Japan)

^f TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE INHIBITOR; RHO KINASE;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL TRANSPLANTATION; CORNEA DISEASE; DISEASE MODEL; ENDOTHELIUM CELL; HUMAN; MACACA FASCICULARIS; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

ANIMALS; CELL TRANSPLANTATION; CELLS, CULTURED; CORNEAL DISEASES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; MACACA FASCICULARIS; PROTEIN KINASE INHIBITORS; RHO-ASSOCIATED KINASES; TREATMENT OUTCOME;

EID: 84970039350     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26113     Document Type: Article

References (36)

1. Joyce, N. C. Proliferative capacity of corneal endothelial cells. Experimental eye research 95, 16-23 (2012).
2. Bourne, W. M. Clinical estimation of corneal endothelial pump function. Trans Am Ophthalmol Soc 96, 229-239; discussion 239-242 (1998).
3. Tan, D. T., Dart, J. K., Holland, E. J. & Kinoshita, S. Corneal transplantation. Lancet 379, 1749-1761 (2012).
4. Patel, S. V. Graft survival and endothelial outcomes in the new era of endothelial keratoplasty. Experimental eye research 95, 40-47 (2012).
5. Mimura, T. et al. Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest Ophthalmol Vis Sci 45, 2992-2997 (2004).
6. Ishino, Y. et al. Amniotic membrane as a carrier for cultivated human corneal endothelial cell transplantation. Invest Ophthalmol Vis Sci 45, 800-806 (2004).
7. Koizumi, N. et al. Cultivated corneal endothelial cell sheet transplantation in a primate model. Invest Ophthalmol Vis Sci 48, 4519-4526 (2007).
8. Okumura, N. et al. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Am J Pathol 181, 268-277 (2012).
9. van der Bogt, K. E. et al. Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 118, S121-129 (2008).
10. Wu, Y. M., Joseph, B., Berishvili, E., Kumaran, V. & Gupta, S. Hepatocyte transplantation and drug-induced perturbations in liver cell compartments. Hepatology 47, 279-287 (2008).
11. Harding, J. & Mirochnitchenko, O. Preclinical studies for induced pluripotent stem cell-based therapeutics. The Journal of biological chemistry 289, 4585-4593 (2014).
12. Hibino, N. et al. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. The Journal of thoracic and cardiovascular surgery 143, 696-703 (2012).
13. Yang, J. J., Liu, J. F., Kurokawa, T., Kitada, K. & Gong, J. P. Hydrogels as feeder-free scaffolds for long-term self-renewal of mouse induced pluripotent stem cells. Journal of tissue engineering and regenerative medicine 9, 375-388 (2015).
14. Forbes, S. J., Gupta, S. & Dhawan, A. Cell therapy for liver disease: From liver transplantation to cell factory. Journal of hepatology 62, S157-169 (2015).
15. Ohgushi, M. et al. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell stem cell 7, 225-239 (2010).
16. Okumura, N. et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci 50, 3680-3687 (2009).
17. Peh, G. S. et al. The effects of Rho-associated kinase inhibitor Y-27632 on primary human corneal endothelial cells propagated using a dual media approach. Sci Rep 5, 9167 (2015).
18. Matsubara, M. & Tanishima, T. Wound-healing of the corneal endothelium in the monkey: a morphometric study. Jpn J Ophthalmol 26, 264-273 (1982).
19. Matsubara, M. & Tanishima, T. Wound-healing of corneal endothelium in monkey: an autoradiographic study. Jpn J Ophthalmol 27, 444-450 (1983).
20. Price, F. W. Jr. & Price, M. O. Evolution of endothelial keratoplasty. Cornea 32 Suppl 1, S28-32 (2013).
21. Allan, B. D., Terry, M. A., Price, F. W. Jr., Price, M. O., Griffin, N. B. & Claesson, M. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea 26, 1039-1042 (2007).
22. Price, M. O., Jordan, C. S., Moore, G. & Price, F. W. Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors. The British journal of ophthalmology 93, 391-395 (2009).
23. Dapena, I., Ham, L., Netukova, M., van der Wees, J. & Melles, G. R. Incidence of early allograft rejection after Descemet membrane endothelial keratoplasty. Cornea 30, 1341-1345 (2011).
24. Anshu, A., Price, M. O. & Price, F. W. Jr. Risk of corneal transplant rejection significantly reduced with Descemet's membrane endothelial keratoplasty. Ophthalmology 119, 536-540 (2012).
25. Li, J. Y., Terry, M. A., Goshe, J., Shamie, N. & Davis-Boozer, D. Graft rejection after Descemet's stripping automated endothelial keratoplasty: graft survival and endothelial cell loss. Ophthalmology 119, 90-94 (2012).
26. Wu, E. I., Ritterband, D. C., Yu, G., Shields, R. A. & Seedor, J. A. Graft rejection following descemet stripping automated endothelial keratoplasty: features, risk factors, and outcomes. American journal of ophthalmology 153, 949-957 e941 (2012).
27. Hjortdal, J., Pedersen, I. B., Bak-Nielsen, S. & Ivarsen, A. Graft rejection and graft failure after penetrating keratoplasty or posterior lamellar keratoplasty for fuchs endothelial dystrophy. Cornea 32, e60-63 (2013).
28. Joyce, N. C. Proliferative capacity of the corneal endothelium. Prog Retin Eye Res 22, 359-389 (2003).
29. Peh, G. S., Toh, K. P., Wu, F. Y., Tan, D. T. & Mehta, J. S. Cultivation of human corneal endothelial cells isolated from paired donor corneas. PLoS One 6, e28310 (2011).
30. Peh, G. S., Beuerman, R. W., Colman, A., Tan, D. T. & Mehta, J. S. Human corneal endothelial cell expansion for corneal endothelium transplantation: an overview. Transplantation 91, 811-819 (2011).
31. Shima, N., Kimoto, M., Yamaguchi, M. & Yamagami, S. Increased proliferation and replicative lifespan of isolated human corneal endothelial cells with L-ascorbic acid 2-phosphate. Invest Ophthalmol Vis Sci 52, 8711-8717 (2011).
32. Okumura, N., Kay, E. P., Nakahara, M., Hamuro, J., Kinoshita, S. & Koizumi, N. Inhibition of TGF-beta Signaling Enables Human Corneal Endothelial Cell Expansion in vitro for Use in Regenerative Medicine. PLoS One 8, e58000 (2013).
33. Nakahara, M. et al. Corneal endothelial expansion promoted by human bone marrow mesenchymal stem cell-derived conditioned medium. PLoS One 8, e69009 (2013).
34. Okumura, N. et al. Laminin-511 and - 521 enable efficient in vitro expansion of human corneal endothelial cells. Invest Ophthalmol Vis Sci 56, 2933-2942 (2015).
35. Okumura, N., Kinoshita, S. & Koizumi, N. Cell-based approach for treatment of corneal endothelial dysfunction. Cornea 33 Suppl 11, S37-41 (2014).
36. Bailey, A. M. Balancing tissue and tumor formation in regenerative medicine. Science translational medicine 4, 147fs128 (2012).